CLDN1 and breast carcinoma: However, in yet another study though using breast cancer cells, MEK1 inhibition neither affected the mRNA or protein levels of claudin-1, occludin and/or ZO-1 nor altered the subcellular cytoplasmic distribution of claudin-1 to be more membrane specific [79].